BEAUTY EDITORIALBEAUTY EDITORIALBEAUTY EDITORIALBEAUTY EDITORIAL

The Science of Skin

    Science of Skin 2026 - Explained & Winners

    Science of Skin 2026 - Explained & Winners

    The 2026 Science of Skin Awards recognize ten brands whose products meet a standard of scientific validity that goes beyond marketing language. In this solo episode, Skin Anarchy host Dr. Ekta Yadav walks through every winner, from e.l.f. Beauty at enterprise scale to exosome characterization data, microbiome biotechnology, peptide manufacturing, teledermatology, and a brand new category built on oxytocin signaling. Below is the full breakdown of who won, what earned each brand recognition, and what the selections say about where skin science is heading.

    Congratulations to all the winners: e.l.f. beauty, Exocellure Dermaceuticals, First Aid Beauty, Hydrinity, Hypothesis, DRMTLGY, XOMD, Musely, Kate Somerville, and Routine Skin

    What are the Science of Skin Awards?

    The Science of Skin Awards are an annual recognition program from Skin Anarchy that honors ten skincare brands per year for scientific validity and demonstrated efficacy rather than trend visibility. The program exists to give consumers a reliable signal in a category where claims often outpace evidence, and as the host explains, “these awards are incredibly meaningful to us here at Skin Anarchy because for us they represent something that is very much needed in a very overcrowded space such as skin care.” Selection weighs formulation logic, mechanism, and whether a brand can prove that its products do what the label says.

    Who won the 2026 Science of Skin Awards?

    The 2026 Science of Skin Award winners are e.l.f. Beauty, Exocellure Dermaceuticals, First Aid Beauty, Hydrinity, Hypothesis Bio, DRMTLGY, XOMD, Musely, Kate Somerville, and Routine Skin. The list spans mass market accessibility, regenerative science, microbiome biotechnology, professional grade formulation, teledermatology, and peptide manufacturing. What connects them is a shared refusal to treat novelty as a substitute for evidence, or as the episode puts it, brands “representing a multitude of different characteristics that I think are incredibly important” to an industry trying to close the gap between consumer care and dermatological rigor.

    Why did e.l.f. Beauty win a Science of Skin Award at enterprise scale?

    e.l.f. Beauty won on an enterprise scale for delivering clinically meaningful formulations at accessible price points with unusual consistency across a large portfolio. “I have never seen a company of this scale do this so consistently,” the host says, pointing to a portfolio strategy where skin health precedes marketing narrative. The recognition acknowledges something structurally difficult: maintaining formulation discipline while operating at mass volume in a saturated market.

    Which e.l.f. Beauty brands are worth turning to for proven skincare actives?

    RODE, Well People, Naturium, and e.l.f. SKIN are the portfolio brands called out for reliable access to well formulated actives. Whether the need is an encapsulated retinoid, hyaluronic acid, a peptide serum, or azelaic acid, “all of these brands are something you can come to every time you don’t know what to buy,” the host says. The through line is dependability on the tried and true actives rather than a rotating cast of novel ingredients.

    How do you know if an exosome skincare product actually contains exosomes?

    You verify it through characterization data, specifically surface markers such as CD81 that confirm the particles are genuine vesicles rather than cellular debris. Exocellure Dermaceuticals supplied exactly that when asked, and the host is explicit about the request: “I asked them straight up for all of their data around characterization and they were able to provide very compelling evidence.” In a category where the word exosome appears on labels far more often than the data supporting it does, characterization is the dividing line between a regenerative product and a marketing claim.

    Why do exosomes lose bioactivity at room temperature?

    Exosomes degrade because the vesicle membrane is held together by surface tension that relaxes once the particle thaws, releasing the cargo that gives the product its activity. Anyone working in aesthetics has run into this, and as the host notes, “you know that exosomes lose their bioactivity when they are thawed and especially when they are sitting at room temperature.” Exocellure addresses it by encapsulating individual particles, which is what makes room temperature shelf stability possible and what allows the brand to build its professional and post treatment protocols on consistent dosing.

    What made First Aid Beauty a pioneer in skin barrier care?

    First Aid Beauty built barrier repair into a functional product category years before barrier health became a mainstream conversation. The brand was serving compromised, eczema prone, and rosacea prone skin when few others were, and as the host puts it, “they were one of the first to actually put barrier health front and center in the skincare space.” That early positioning is now the industry standard, which is precisely the case for recognizing it.

    What does colloidal oatmeal do for compromised skin?

    Colloidal oatmeal calms irritation and supports barrier function, and newer research points to benefits well past simple soothing. It appears across the First Aid Beauty lineup at 0.5%, and the host notes that “now we are learning how much benefit there is to using colloidal oatmeal beyond just reducing irritation or reducing… sensitivity.” For skin that is reactive, inflamed, or recovering, it remains one of the most quietly evidence backed ingredients in the category.

    How is Hydrinity rethinking hyaluronic acid beyond hydration?

    Hydrinity treats hyaluronic acid as a repair signal rather than a surface hydrator, building technologies around how it supports recovery, barrier function, and tissue repair. That framing is why the brand became a favorite for post procedure protocols among aesthetic providers. As the host describes it, Hydrinity “first established itself by rethinking one of skincare’s most familiar ingredients, which was hyaluronic acid,” a reframe that turned a commodity molecule into a functional one.

    What is Hydrinity RetaXome and why does delivery science matter?

    RetaXome pairs retinaldehyde with a biomimetic exosome delivery system designed to improve stability, penetration, and tolerability, three variables that determine whether a retinoid performs as intended. Delivery has become the limiting factor as the market shifts toward regenerative actives, and the host is direct about it: “when you look at ingredients like that, you cannot leave delivery science behind.” Formulation vehicles have to evolve in parallel with the molecules they carry, or the biology never reaches the target.

    What is precision microbiome engineering in skincare?

    Precision microbiome engineering means selectively removing disease associated microbes while leaving the skin’s beneficial flora intact, in contrast to broad spectrum antimicrobials that strip everything. Hypothesis Bio was, in the host’s words, “founded on the belief that the future of dermatology lies in precision microbiome engineering,” and built patented enzyme technologies to execute it. The approach reframes microbiome care as a targeting problem rather than a probiotic marketing angle.

    How do bioengineered enzymes target acne and eczema bacteria?

    Bioengineered enzymes work by recognizing specific microbial targets, which allows a formula to act on one problem organism without collapsing the surrounding ecosystem. Hypothesis Bio’s eczema and acne products are built on exactly this logic, with the host explaining that “they’re both utilizing independent bioengineered enzymes that will specifically go and target microbes such as Staph aureus or C. acnes, respectively.” What makes it notable is the translation itself, since this class of academic research rarely survives the trip from lab bench to at home product.

    Why did DRMTLGY win a Science of Skin Award?

    DRMTLGY won for taking formulations developed over decades for dermatologists and plastic surgeons and making them available directly to consumers. “They were formulating for dermatologists, for plastic surgeons, for decades,” the host explains, before the founders recognized that patients loved the products but could not buy them independently. The Needleless collection reflects the same discipline, targeting collagen production and extracellular matrix health rather than chasing whatever ingredient is trending that month.

    What are moodceuticals and how does XOMD OX Factor™ technology work?

    Moodceuticals are a new product category built on the premise that skin health and emotional state are biologically linked, not just correlated. XOMD, founded by facial plastic surgeon Dr. Steven Dayan and dermatologist Dr. Sabrina Fabi, grounds the concept in oxytocin research and its patent pending OX Factor technology, positioning the brand at the front of an emerging psychodermatology category. The founders recognized that “the effects of healthy skin extend way beyond what we see in the mirror,” and built a formulation approach around a signaling pathway the category had largely ignored.

    How does Musely make prescription strength dermatology more accessible?

    Musely uses telemedicine and physician guided treatment plans to deliver customized prescription formulations for melasma, acne, hair loss, rosacea, and photoaging without an in office visit. Its formulas combine clinically established agents such as hydroquinone, tretinoin, tranexamic acid, and azelaic acid, selected for the individual patient and paired with ongoing physician oversight. That continuity matters enormously, because as the host puts it, “there are so many people right now that just simply do not have access to dermatological care,” whether they live in a rural community or face appointment waits measured in months.

    What made Kate Somerville ExfoliKate a turning point in exfoliation?

    ExfoliKate popularized multimodal exfoliation by combining alpha hydroxy acids, beta hydroxy acids, fruit enzymes, and physical polishing agents in a single treatment. The host calls it a product that “was a game changer in the industry,” and credits the brand’s esthetician origins for that practical, results first formulation instinct. Kate Somerville’s lineup keeps returning to the same principle, that knowing when and how to use an ingredient matters as much as the ingredient itself.

    Why is GHK-Cu trending for the wrong reasons?

    GHK-Cu is trending on ingredient recognition rather than formulation quality, and most products using it are not dosed at concentrations capable of driving the repair biology the peptide is known for. Routine Skin comes out of peptide manufacturing rather than ingredient sourcing, which is the distinction the host emphasizes: “they’re not buying their peptides from other companies and hoping that it just works.” Getting concentration and sequence right matters beyond one brand, because consumers who see nothing happen stop believing the category can work at all.

    Listen to the full 2026 Science of Skin Awards episode on the Skin Anarchy podcast, available on Apple Podcasts, Spotify, and wherever you get your shows.

    The Early Hormonal Shift: How Your 30s Reshape Mood, Mental Health, Stress, and Skin

    The Early Hormonal Shift: How Your 30s Reshape Mood, Mental Health, Stress, and Skin

    Over the last several years, hormonal health has been discussed primarily through the lens of perimenopause, framed as a transition that begins in the 40s and is defined by recognizable symptoms. What is rarely addressed is the stage that precedes it, which is a period where hormone levels remain within normal ranges, cycles appear regular, and nothing is clinically flagged, yet the internal experience shifts in ways that are noticeable and persistent, impacting the lives of many. In the early to mid 30s, these changes do not present as a single issue, but rather appear as small inconsistencies across systems that previously behaved predictably. For example: mood becomes less steady regardless of exterior triggers, stress responses linger for longer periods of time, sleep is no longer deep and restful, cognitive patterns change, and even skin reacts differently to the same routine. None of these changes are things women never experience but when looked at all together, they reflect a transition in how regulation is maintained. The early hormonal shift is a phase defined by variability instead of decline. The body is still functioning, but the stability that once held these systems together begins to loosen. Why Early Perimenopause Is Overlooked and Why It Matters Perimenopause is often described as a transition that begins in the mid 40s, but the earliest regulatory changes can appear a decade earlier. These early shifts do not show up as irregular cycles or measurable hormonal decline, but rather as changes in timing, signaling, and receptor sensitivity that occur long before hormone levels fall outside the normal range. The reason this stage is overlooked is structural. Most clinical definitions rely on cycle irregularity, which is a late stage marker. Most research focuses on women 45 and older and most public conversations frame perimenopause as a period defined by hot flashes, night sweats, and clear hormonal drops; all things that are leading to menopause. None of these frameworks capture what happens as early as the early 30s, when the first signs are neurological and regulatory rather than reproductive. Early perimenopause is characterized by timing drift in the HPO axis, inconsistent estrogen peaks, and fluctuating progesterone responses. These shifts influence neurotransmitter systems, stress buffering, sleep architecture, and inflammatory regulation long before they affect cycle length. As a result, many people experience changes in mood, stress tolerance, cognition, and skin without a clear explanation for why their baseline feels different. Understanding this stage matters because it provides a framework for interpreting changes that are real but rarely named. It shifts the focus from symptoms to regulation, from isolated experiences to a coordinated transition, and from self blame to physiology. The HPO Axis: When Timing Becomes Less Precise The hypothalamic pituitary ovarian (HPO) axis operates on a timing system that depends on rhythmic signaling. The hypothalamus releases GnRH in pulses, the pituitary responds with LH and FSH, and the ovaries produce estrogen and progesterone in return. This loop functions like a metronome. In simpler terms, the HPO axis is the communication system between the brain and the ovaries. The hypothalamus acts like the starter, sending small timed signals. The pituitary acts like the messenger, passing those signals along; and the ovaries act like the responders, releasing estrogen and progesterone based on those messages. When this timing is steady, hormones stay predictable. When the timing becomes irregular, even slightly, the entire system becomes less consistent. In the early 30s, the first change is not a drop in hormone levels but a shift in timing precision. Pulses become slightly irregular, causing ovarian response to vary from cycle to cycle. That shift alters how estrogen and progesterone fluctuate across the entire month. Estrogen and Serotonin: Why Mood Feels Less Predictable Estrogen regulates serotonin synthesis, breakdown, and receptor sensitivity (Bethea, 2002). When estrogen is stable, serotonin signaling is stable. When estrogen fluctuates, serotonin becomes less predictable. This does not necessarily create dramatic mood swings; it produces a variability, including: Emotional responses that feel more aggressive on some days and steadier on others Motivation that shifts without clear cause A sense of being slightly “off” without being actually distressed These changes reflect shifts in neurotransmitter regulation rather than personality or permanent emotional state. Additionally, estrogen’s influence on serotonin affects the entire serotonin system at multiple levels. Estrogen increases the expression of tryptophan hydroxylase (the enzyme that starts serotonin production), the rate‑limiting step in serotonin synthesis (Bethea, 2002). It also reduces the activity of the serotonin transporter (SERT) (the protein that clears serotonin away), slowing reuptake and allowing serotonin to remain active in the synapse for longer periods. At the receptor level, estrogen modulates 5 HT1A and 5 HT2A receptors, which are the ones that shape emotional tone, cognitive flexibility, and how the brain interprets social and environmental cues. Estrogen also influences the firing patterns of serotonergic neurons in the dorsal raphe nucleus, the brain region that distributes serotonin throughout the entire system. When estrogen fluctuates, these neurons shift between high fidelity signaling and more irregular firing patterns. This directly affects mood steadiness, emotional filtering, and how quickly the brain can shift between states like focus, calm, and motivation. What this means for mental health and mood: Changes in tryptophan hydroxylase can affect how easily the brain generates a sense of emotional steadiness. Changes in SERT activity influence how long emotional signals “stick,” which can make reactions feel sharper or linger longer. Changes in 5 HT1A receptors affect the brain’s ability to down shift from stress or heightened emotion. Changes in 5 HT2A receptors influence cognitive flexibility like how easily you can shift perspective, adapt, or reframe. Changes in dorsal raphe firing affect the overall rhythm of mood, motivation, and emotional processing. It is important to understand that given that estrogen affects how much serotonin is made, how long it stays active, and how strongly the brain responds to it, when it varies, the entire serotonin system becomes less predictable. This can drastically affect how the brain filters and interprets everyday experiences. How Hormonal Variability Alters Emotional Processing Hormonal changes influence emotional processing not by creating new emotions but by altering the systems that regulate them. Estrogen interacts with serotonin pathways that shape mood stability and cognitive flexibility (Bethea, 2002). Progesterone and its metabolite allopregnanolone modulate GABA A receptors, which help regulate intensity and recovery (Reddy, 2010). These systems do not operate independently. They form a network that determines how the brain responds to internal and external stimuli. When estrogen fluctuates, serotonin receptor density and signaling efficiency shift. This affects how the brain filters emotional information, making reactions feel entirely different or extreme. At the same time, inconsistent progesterone patterns alter GABA A receptor sensitivity, which affects the brain’s ability to down regulate after stress. These changes influence the amygdala, which processes emotional salience, and the prefrontal cortex, which governs regulation and decision making. This explains why many people in their early 30s report feeling “different” emotionally. Mental Health Patterns Shift Even Without Clinical Symptoms Hormonal variability does not create mental health disorders; however, it has been found to influence mental health patterns. These are mainly seen as the everyday cognitive and emotional processes that shape how you feel mainly because these changes during the early perimenopause reflect shifts in specific brain circuits. Several regions are particularly sensitive to estrogen, progesterone, and cortisol: The amygdala, which assigns emotional significance to experiences, becomes more responsive when estrogen fluctuates. This does not generate new emotions; it changes how strongly existing emotions register. The prefrontal cortex, responsible for planning, regulation, and decision making, relies on steady serotonin and GABA input. When those signals vary, tasks that normally feel automatic require more cognitive effort. The hippocampus, which supports memory and contextual processing, is closely tied to cortisol rhythms. When cortisol rises or falls unpredictably, the hippocampus shifts into a more vigilant, energy conserving mode. This can feel like mental fatigue or difficulty retrieving information that is normally easy to access. Seen through this lens, the emotional and cognitive changes of early perimenopause are not signs of being “overly emotional” or “less resilient.” They reflect the fact that the brain is processing information with different circuitry than it did in the person’s 20s. Common experiences include: Lower stress tolerance Anxiety-like sensations Periods of mental fatigue Difficulty sustaining focus Emotional reactivity that fluctuates across the cycle These patterns are subtle but are noticeable enough to have an impact in people’s lives. Nonetheless, they do not indicate pathology; instead they are a sign of regulatory inconsistency. What’s Happening at a Deeper Neuroscience Level Estrogen also influences how efficiently the brain communicates within and between networks. Functional MRI studies show that estrogen fluctuations alter connectivity between the amygdala and the prefrontal cortex, the pathway responsible for regulating emotional responses. When estrogen is inconsistent, this communication becomes less efficient, which can make emotional experiences feel more immediate and harder to modulate. At the same time, progesterone derived neurosteroids like allopregnanolone affect the balance between excitatory and inhibitory signaling, shaping how quickly the brain can return to baseline after stress. How This Shows Up in Cognitive Function These changes also affect cognitive load. When neurotransmitter support varies, the brain compensates by recruiting additional regions to complete the same tasks. This is why people often describe feeling “mentally slower” or “less sharp” even though their actual cognitive ability has not declined. The brain is simply working harder to achieve the same output. GABA, Allopregnanolone, and Stress Recovery Progesterone’s metabolite allopregnanolone enhances GABA activity, which helps the brain regulate intensity and return to baseline (Reddy, 2010). When progesterone patterns become inconsistent, allopregnanolone levels and receptor sensitivity fluctuate. This happens because allopregnanolone is a chemical the body makes from progesterone. It strengthens the calming system in the brain (the GABA system) which is responsible for slowing things down and helping you recover after stress. When progesterone rises and falls less predictably, the amount of allopregnanolone changes too, and the brain’s calming receptors respond differently. This makes stress feel harder to “come down” from, not because stress is higher, but because the recovery system is less consistent. Allopregnanolone, one of the strongest natural calming chemicals the brain makes, binds to GABA A receptors at a site distinct from benzodiazepines, amplifying inhibitory signaling with exceptional potency (Reddy, 2010). The research demonstrated that allopregnanolone can amplify GABA A receptor activity far more strongly than most naturally occurring neurochemicals. It does this by increasing the flow of chloride ions into the neuron, which makes the cell less likely to fire. In practical terms, this means the brain becomes better at dampening intensity, filtering stimulation, and recovering after emotional or sensory load. When levels of allopregnanolone shift, the brain’s ability to apply this “braking system” shifts with it, making everyday demands feel heavier than usual. Even small fluctuations in allopregnanolone levels can meaningfully alter how the brain regulates intensity. During early perimenopause, progesterone variability leads to inconsistent allopregnanolone production, which means the brain’s primary inhibitory system is receiving uneven input. The Unified Neurotransmitter Pathway: How Estrogen and Progesterone Shape Mood, Stress, and Cognition The early hormonal shift becomes clearer when the neurotransmitter systems are viewed as a single pathway rather than separate mechanisms. Estrogen, progesterone, serotonin, GABA, glutamate, and cortisol form an interconnected network that regulates emotional tone, stress recovery, cognitive clarity, and sensory processing. Here is the simplified structure of that pathway: Estrogen → Serotonin: Supports mood stability, cognitive flexibility, and emotional processing (Bethea, 2002). Progesterone → Allopregnanolone → GABA: Supports inhibition, recovery, and the ability to return to baseline (Reddy, 2010). Estrogen → Glutamate Modulation: Influences excitatory signaling and mental energy. Estrogen → HPA Axis Buffering: Regulates cortisol peaks and recovery. When estrogen fluctuates, serotonin and glutamate signaling become inconsistent. When progesterone fluctuates, GABA‑A receptor sensitivity shifts. When both fluctuate, the HPA axis loses stability. The result is not a single symptom but a pattern: Mood variability Stress sensitivity Cognitive fluctuations Changes in sleep depth Altered emotional thresholds Thermoregulation: The Narrowing Comfort Zone Before any classic perimenopausal symptoms appear, many people notice subtle temperature sensitivity. Estrogen helps regulate the hypothalamic thermostat. When estrogen fluctuates, the thermoneutral zone narrows. This means that small temperature changes can start to feel larger, which directly affects sleep. As the body wakes to adjust temperature, sleep is disrupted and naturally shifts to becoming lighter than usual. Estrogen supports slow wave sleep and REM (rapid eye movement) stability. Progesterone’s metabolites help initiate sleep through GABA pathways. When these hormones fluctuate: Sleep becomes lighter Awakenings increase Dreams become more vivid or fragmented Returning to sleep becomes harder This is why people often describe sleep as “shallow” even when duration is unchanged. Cortisol and the Stress Axis The HPA axis is the body’s stress response system and estrogen normally helps keep it balanced so that cortisol, the main stress hormone, rises and falls in a controlled way. When estrogen becomes inconsistent, that control becomes less steady, causing cortisol to surge more easily, linger longer, or shift abruptly, which makes stress feel harder to regulate even when the stressor itself hasn’t changed. This creates a pattern where cortisol does not follow its usual rise and fall rhythm. Instead, it may surge more strongly in the morning, drop sharply in the afternoon, or remain elevated into the evening. These shifts reflect changes in how the endocrine and stress response systems interact and impact mood and mental health. Skin as a Downstream Reflection of Internal Variability Skin is highly sensitive to hormonal rhythm. Estrogen influences fibroblast activity, collagen production, hydration, and inflammatory regulation (Brincat, 2005). When estrogen becomes inconsistent, fibroblast activity becomes inconsistent too. These are the cells that maintain structure and repair. When hormonal input becomes irregular, their output becomes irregular too, appearing as changes in texture, slower recovery, inconsistent hydration, and increased reactivity. As these continue, fibroblast responsiveness changes before any structural differences appear. Moreover, collagen production may vary from cycle to cycle and hyaluronic acid synthesis may fluctuate, causing the extracellular matrix may not maintain the same level of organization. This does not create visible aging, but skin may start feeling differently on a day to day basis even when the routine is unchanged. Barrier function reflects this same pattern. The stratum corneum depends on lipid organization and cohesive cell structure to regulate hydration and protect against irritation (Proksch, 2008). When hormonal signaling becomes irregular, these processes lose consistency. The result is reactivity without a clear trigger, products that were stable for years may suddenly sting, breakouts may appear intermittently and dryness and oiliness may alternate. The Skin Microbiome Responds to Internal Rhythm Sebum composition, pH, and hydration influence the microbiome. Hormonal variability alters these conditions, shifting microbial balance (Dreno, 2018). This can lead to issues like intermittent breakouts, redness, sensitivity and unpredictable responses to usually used products. The microbiome adapts to the environment it is given. When the environment changes frequently, the microbiome becomes less stable, which directly affects inflammation and recovery. How to Support Emotional and Cognitive Regulation These strategies do not treat symptoms, but they support the brain circuits most affected by hormonal variability. Reduce sensory load on high reactivity days: Lowering background noise, reducing multitasking, or simplifying environments helps the amygdala process information more steadily. Anchor the day with predictable cues: Regular wake times, morning light exposure, and structured transitions help stabilize cortisol rhythms. Use cognitive off-ramps: Short breaks that change environment or sensory input like stepping outside, shifting rooms, altering posture can help the prefrontal cortex reset. Support inhibitory pathways naturally: Slow exhalation, warmth, weighted blankets, and deep pressure input activate GABA related circuits. Protect sleep architecture: Morning light, reduced screens at night, and consistent wind down cues help stabilize REM and slow wave sleep. These approaches help the brain work with the conditions it is receiving rather than against them. What This Phase Actually Represents and Its Takeaway The early hormonal shift clarifies a stage that many people experience but rarely have language for. It shows that the changes appearing in mood, stress tolerance, cognition, sleep, and skin are not isolated issues. Understanding this phase reframes what these changes represent. Mood variability becomes a physiological response to shifting estrogen and serotonin interactions, cognitive fluctuations become a consequence of inconsistent neurotransmitter support, stress sensitivity reflects altered buffering within the HPA axis, and skin reactivity becomes a downstream effect of internal variability. Moreover, this phase that is usually ignored is not a collection of unrelated symptoms that all finally lead to menopause. It is a coordinated shift from stable regulation to variable signaling across systems: The brain reflects this through serotonin and GABA variability. The stress system reflects it through altered cortisol dynamics. Sleep reflects it through changes in architecture and thermoregulation. Skin reflects it through fibroblast activity, barrier integrity, and microbiome balance. The defining feature of this stage is not hormonal decline and recognizing this helps create a more accurate framework for interpreting what the body is doing. Instead of searching for single causes or quick corrections, the focus shifts to understanding patterns, timing, and regulation. Knowledge provides a structure for understanding why these changes occur and how they relate to one another. And while the system is still functioning, it is simply no longer functioning under the same stable conditions as it was before. These signals explain why the early 30s can feel different even when everything appears normal externally.
    PCOS and the Skin: What Dermatology Reveals About a Lifelong Endocrine Disorder

    PCOS and the Skin: What Dermatology Reveals About a Lifelong Endocrine Disorder

    Most people are taught to think of PCOS (polycystic ovary syndrome) as a reproductive issue; something connected to irregular periods, fertility struggles, or ovarian cysts. But for many, that’s not actually where the story begins. It often starts with the skin. For example, from a dermatology perspective, what is being reflected on the skin is not incidental, it is often the earliest clinical clue. Dermatologists are trained to look for patterns across the skin, hair, and scalp, and in conditions like PCOS, those patterns can reveal systemic dysfunction long before a formal diagnosis is made. What might appear as isolated concerns, such as acne, hair thinning, or pigmentation changes, often form a recognizable picture when viewed together. It is relevant to understand the ways it can manifest itself because in most cases, years before a diagnosis is ever made, people tend to notice things that don’t quite add up but have no concise answer to either. This includes acne that doesn’t go away after the teen years, hair thinning at the crown, new or worsening facial hair, or patches of darker, thicker skin. These changes are often treated as isolated concerns and are seen as something to fix or something to manage (Farhan, 2025). However, these are not random symptoms and instead should be seen as signals that our body is giving. PCOS is not just a reproductive condition. It is a whole body hormonal and metabolic disorder, and the skin is one of the first places it shows itself (Farhan, 2025). As Dr. Elizabeth Housman explains, PCOS is one of the few conditions where the skin can actually reflect hormone activity more clearly than blood tests (Housman, 2014). That can feel surprising at first because how can your skin “know” something your lab results don’t? The answer has to do with how hormones behave in the body. Labs and Results Hormones called androgens, like testosterone, play a big role in PCOS. They affect things like oil production, hair growth, and how hair follicles function. But here’s where it gets complicated, especially because this is where a lot of people get overlooked: Even if your bloodwork comes back “normal,” your skin might still be experiencing high androgen activity. It is important to understand that skin isn’t just passively receiving hormones, it is actively processing them. And that means that sometimes it can: Be extra sensitive to androgens Convert them into a stronger form (called DHT) right inside the skin itself This happens because the skin is not just a target of circulating hormones, it is also an active endocrine organ, meaning it doesn’t simply receive hormonal signals from the body, it can also process and transform them directly. Within the skin, enzymes such as 5‑alpha reductase convert weaker androgens like testosterone into more potent forms like dihydrotestosterone (DHT). This conversion takes place directly inside hair follicles and sebaceous glands, amplifying hormonal signals locally even when blood levels appear within normal ranges. In practical terms, this means that two people with identical lab values can experience completely different skin outcomes, depending on how their skin processes and responds to these hormones at a local level. So while your labs may fall within normal ranges, your skin could be dealing with a very different reality. Making this one of the reasons so many people struggle for years without answers. The visible symptoms are there, but they don’t always match standard testing. How These Changes Actually Show Up When you zoom in, several things are happening at once in PCOS: Hormones are signaling the skin to produce more oil Skin cells may shed differently, clogging pores more easily Inflammation is more active in the background Insulin, hormone that regulates blood sugar, isn’t working as efficiently Together, these disrupt what’s called the hair follicle and oil gland unit, which are basically the tiny system responsible for your pores, hair growth, and oil production. That’s why PCOS can show up in ways like: Acne that lingers or worsens in adulthood Oily skin that feels hard to control Hair thinning, especially near the crown or part line Increased hair growth on the face or body Darkened, velvety skin (often on the neck, underarms, or groin), which can be linked to insulin resistance (Farhan, 2025) Looking Beyond Acne: A Deeper Look Into Other Symptoms While acne is often the most recognized feature, dermatologists look for a broader set of skin findings that reflect different underlying pathways in PCOS. They take a more structured approach by grouping them based on what may be driving them internally. This framework helps connect both visible and less visible symptoms to underlying hormonal and metabolic activity. How Dermatologists Interpret Skin and Systemic Symptoms in PCOS Androgen driven Symptoms and findings: acne, oily skin, facial or body hair growth, hair thinning at the crown of the head What it means: strong response to androgen hormones Insulin related Symptoms and findings: dark and velvety skin (acanthosis nigricans), skin tags (acrochordons), central weight distribution (fat stored more around the abdomen), persistent inflammation What it means: the body is not using insulin effectively, affecting both metabolic function and skin behavior Inflammatory Symptoms and findings: increased sensitivity, slower healing, more reactive skin, gut problems What it means: the skin is more prone to inflammation and less able to repair itself Cardiometabolic Symptoms and findings: insulin resistance, prediabetes and type 2 diabetes, cholesterol imbalance, increased long term cardiovascular risk What it means: higher long term metabolic and heart risk The information above was adapted from dermatologic and metabolic findings in PCOS research (Housman, 2014; Farhan, 2025; Geraci, 2025). Taken together, these patterns move the conversation beyond individual symptoms, highlighting how changes in the skin and body can serve as visible markers of deeper hormonal and metabolic processes. Lean PCOS and What’s Happening Internally Another common misunderstanding about PCOS is that it only affects people who have a higher BMI (body mass index). In reality, many people with PCOS have what is considered an average BMI. This is sometimes referred to as lean PCOS (Elnashar, 2024). But “lean” doesn’t mean unaffected by the many symptoms that come with PCOS. Someone can look healthy on the outside and still be dealing with: Insulin resistance Hormonal imbalance Inflammation Changes in how fat is stored internally, especially with how it sits around organs, not just under the skin (Dutta and Maddukuri, 2024). So even without visible weight changes, the body may still be under metabolic strain. This is why relying on appearance or even BMI alone can miss a large number of people who are still at risk (Elnashar, 2024). Why It Sometimes Shows Up Later in Life PCOS often begins early, but it doesn’t always get recognized early. For many, symptoms become more noticeable in their 30s or 40s, especially during perimenopause, when hormone levels naturally start shifting (Agarwal, 2022). As estrogen and progesterone fluctuate, underlying androgen activity (which may have been more balanced before) can become more noticeable. That can look like: New acne after years of clear skin Gradual hair thinning Changes in cycle regularity It’s easy to assume this is just part of aging, but in many cases, it’s actually PCOS becoming more visible, not newly appearing. And importantly, menopause doesn’t make PCOS go away. The hormonal patterns can continue, just in a different form (Agarwal, 2022). The Acne Piece Is Bigger Than You Think Acne in PCOS is often blamed entirely on hormones or insulin, but there’s another layer that’s getting more attention: the microbiome. This refers to the balance of bacteria in your gut and on your skin. Hormones can change the type and amount of oil your skin produces, which in turn affects which bacteria thrive on the skin. At the same time, imbalances in gut bacteria can increase inflammation and affect how the body handles insulin and hormones (Sánchez‑Pellicer, 2022). So instead of one single cause, PCOS-related acne is often a combination of: Hormonal signaling Immune response Bacterial balance Metabolic function Emerging research also suggests certain gut bacteria may directly influence acne risk, reinforcing how connected these systems are (Cao, 2025). Furthermore, this connection is often referred to as the gut-skin axis, a bidirectional relationship where changes in gut microbiota can influence systemic inflammation, hormone regulation, and insulin sensitivity, all of which play a role in PCOS. At the same time, hormonal shifts can alter the composition of the skin, which changes the environment for skin resident bacteria. Rather than acting as a single cause, the microbiome functions as a modifier, shaping how strongly PCOS expresses itself through the skin. This helps explain why individuals with similar hormonal profiles can experience very different dermatological outcomes. Why All of This Matters Beyond the Skin It can be tempting to think of symptoms like acne, hair changes, skin texture as mainly cosmetic. But in PCOS, they often come before deeper health issues are identified. Over time, PCOS is linked to higher risks of: Type 2 diabetes High blood pressure Cholesterol imbalances Cardiovascular disease (Geraci, 2025) And these risks can exist even if someone doesn’t “look” like the typical picture associated with metabolic illness (Dutta and Maddukuri, 2024). That’s why the skin matters so much. It can act as an early warning system given that it is one of the first places the body shows that something deeper is happening. Seeing Skin Differently When you start to look at these skin changes not as random problems but as meaningful signals that our body gives us, it can shift the way PCOS is understood. It becomes less about chasing isolated symptoms and more about connecting the dots. These are all ways the body communicates. And for many people with PCOS, it’s where the condition speaks first.
    What Your Skin is Actually Craving — Based on the Skin Renewal Cycle

    What Your Skin is Actually Craving — Based on the Skin Renewal Cycle

    All About Acids: From Glycolic & Hyaluronic, to Azelaic and Beyond

    All About Acids: From Glycolic & Hyaluronic, to Azelaic and Beyond

    The Second Signal: Why Menopause Marks the Most Overlooked Longevity Transition in Hair and Skin Health

    The Second Signal: Why Menopause Marks the Most Overlooked Longevity Transition in Hair and Skin Health